Citation Impact
Citing Papers
New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo
2010 Standout
Treg-based immunotherapy for antigen-specific immune suppression and stable tolerance induction: a perspective
2023 StandoutNobel
Radiation-Induced CXCL16 Release by Breast Cancer Cells Attracts Effector T Cells
2008
Regulatory T cells in autoimmune kidney diseases and transplantation
2023 StandoutNobel
Antitumor Activity of Rapamycin in a Transgenic Mouse Model of ErbB2-Dependent Human Breast Cancer
2005
The challenges and molecular approaches surrounding interleukin-2-based therapeutics in cancer
2018
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
dCas9 fusion to computer-designed PRC2 inhibitor reveals functional TATA box in distal promoter region
2022 StandoutNobel
Delivery strategies of cancer immunotherapy: recent advances and future perspectives
2019
Antibody-cytokine fusion proteins: Biopharmaceuticals with immunomodulatory properties for cancer therapy
2018
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
2007 Standout
Natural Health Products That Inhibit Angiogenesis: A Potential Source for Investigational New Agents to Treat Cancer—Part 1
2006 Standout
Targeting Ferroptosis to Iron Out Cancer
2019 Standout
Therapeutic Potential of Moringa oleifera Leaves in Chronic Hyperglycemia and Dyslipidemia: A Review
2012 Standout
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
2008 Standout
Activation of the PI3K/Akt pathway and chemotherapeutic resistance
2002
TGF-β: the master regulator of fibrosis
2016 Standout
Phylogeny of the bacterial superfamily of Crp-Fnr transcription regulators: exploiting the metabolic spectrum by controlling alternative gene programs
2003
Cyclotherapy: Protection of Normal Cells and Unshielding of Cancer Cells
2002
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
The biology and function of fibroblasts in cancer
2016 Standout
Lessons from the Drug Discovery of Lapatinib, a Dual ErbB1/2 Tyrosine Kinase Inhibitor
2006
Engineering interferons and interleukins for cancer immunotherapy
2022
Anticancer activities of histone deacetylase inhibitors
2006 Standout
Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression
2016
Classification and biology of tumour associated stromal cells
2015
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Fibrocytes: emerging effector cells in chronic inflammation
2011
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Biochemistry, regulation and genomics of haem biosynthesis in prokaryotes
2002
Insect pathogens as biological control agents: Back to the future
2015 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Role of the Polycomb Repressive Complex 2 (PRC2) in Transcriptional Regulation and Cancer
2016
A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism
2018
Targeting apoptosis in cancer therapy
2020 Standout
Inflammation: the incubator of the tumor microenvironment
2022
Broadening horizons: the role of ferroptosis in cancer
2021 Standout
Overcoming the resistance of codling moth against conventional Cydia pomonella granulovirus (CpGV-M) by a new isolate CpGV-I12
2008
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Transcriptional Repression of Protein Kinase Cα via Sp1 by Wild Type p53 Is Involved in Inhibition of Multidrug Resistance 1 P-Glycoprotein Phosphorylation
2004
Antioxidant and anticancer activities of chamomile (Matricaria recutita L.)
2019
Modulation of EZH2 expression in T cells improves efficacy of anti–CTLA-4 therapy
2018 StandoutNobel
Regulatory T cells in the treatment of disease
2018
Photodynamic therapy: a new antimicrobial approach to infectious disease?
2004 Standout
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
New Treg cell-based therapies of autoimmune diseases: towards antigen-specific immune suppression
2020 StandoutNobel
Reactive oxygen species, cellular redox systems, and apoptosis
2010 Standout
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
ROS signalling in the biology of cancer
2017 Standout
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress
2018
Differentiation of Circulating Monocytes into Fibroblast-Like Cells
2012
Ionizing radiation activates IGF-1R triggering a cytoprotective signaling by interfering with Ku-DNA binding and by modulating Ku86 expression via a p38 kinase-dependent mechanism
2006
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Mechanisms of Cell Death in Oxidative Stress
2006
NAD + /NADH and NADP + /NADPH in Cellular Functions and Cell Death: Regulation and Biological Consequences
2007 Standout
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Recent Fascinating Aspects of the CuAAC Click Reaction
2020 StandoutNobel
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Comprehensive Assessment of the Regulons Controlled by the FixLJ-FixK2-FixK1Cascade inBradyrhizobium japonicum
2008
Disparate Oxygen Responsiveness of Two Regulatory Cascades That Control Expression of Symbiotic Genes in Bradyrhizobium japonicum
2003
Regulatory T Cells and Human Disease
2020 StandoutNobel
Fasting and cancer treatment in humans: A case series report
2009 Standout
Marine natural products
2015 Standout
Resistance to Cydia pomonella granulovirus follows a geographically widely distributed inheritance type within Europe
2013
The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic study
2006
Occurrence, Classification, and Biological Function of Hydrogenases: An Overview
2007 Standout
Superior Activity of the Combination of Histone Deacetylase Inhibitor LAQ824 and the FLT-3 Kinase Inhibitor PKC412 against Human Acute Myelogenous Leukemia Cells with Mutant FLT-3
2004
β1 Integrin Inhibition Dramatically Enhances Radiotherapy Efficacy in Human Breast Cancer Xenografts
2008
Computational Evolution of Threonine-Rich β-Hairpin Peptides Mimicking Specificity and Affinity of Antibodies
2019 StandoutNobel
Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?
2014 StandoutNobel
Targeting an engineered cytokine with interleukin-2 and interleukin-15 activity to the neovasculature of solid tumors
2020
The Mononuclear Molybdenum Enzymes
2014 Standout
Tumor Necrosis Factor-α Decreases Akt Protein Levels in 3T3-L1 Adipocytes via the Caspase-Dependent Ubiquitination of Akt
2005
Combined-Modality Treatment of Solid Tumors Using Radiotherapy and Molecular Targeted Agents
2003
Kinase Inhibitors of Marine Origin
2013
Effects of interleukin-2 in immunostimulation and immunosuppression
2019
Mechanisms of Renal Fibrosis
2017 Standout
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Contribution of bone marrow-derived fibrocytes to liver fibrosis.
2015
Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy
2020 StandoutNobel
Important Flavonoids and Their Role as a Therapeutic Agent
2020 Standout
Works of Daniel Zingg being referenced
Differential Activation of the Phosphatidylinositol 3′-Kinase/Akt Survival Pathway by Ionizing Radiation in Tumor and Primary Endothelial Cells
2004
The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy
2017
The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors
2015
Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma
2012
Degradation of PKB/Akt protein by inhibition of the VEGF receptor/mTOR pathway in endothelial cells
2004
Responsiveness of fibrocytes to toll-like receptor danger signals
2007
The phosphatidylinositide 3'-kinase/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase C.
2001
One of Two hemN Genes in Bradyrhizobium japonicum Is Functional during Anaerobic Growth and in Symbiosis
2001
Madex Plus and Madex I12 overcome Virus Resistance of Codling Moth
2008
Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2
2016